Erratum to "Improving global monitoring of vaccine safety: A quantitative analysis of adverse event reports in the WHO Adverse Reactions Database" [Vaccine 2008;26(9):1185-94] (DOI:10.1016/j.vaccine.2007.12.033);Improving global monitoring of vaccine safety: A quantitative analysis of adverse event reports in the WHO Adverse Reactions Database

Vaccine

Volumn 26, Issue 9, 2008, Pages 1185-1194

  Letourneau, Megan ^a,b   Wells, George ^a,c   Walop, Wikke ^a,d   Duclos, Philippe ^e  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Pharmacovigilance; Programme for International Drug Monitoring; Vaccine

Indexed keywords

VACCINE;

ACHIEVEMENT; AGE DISTRIBUTION; ARTICLE; DATA BASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; INTERNATIONAL COOPERATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

EID: 39149125439     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.03.057     Document Type: Erratum

References (19)

1. In: Hugman B. (Ed). Viewpoint part 2-watching for safer medicines, the scientific and technical story (2004), The Uppsala Monitoring Centre, Uppsala (Sweden)
2. Burgio G.R. The thalidomide disaster briefly revisited. Eur J Pediatr 136 (1981) 229-230
3. The Uppsala Monitoring Centre [homepage on the Internet]. Uppsala (Sweden): the Uppsala Monitoring Centre; c2006 [updated 2006 Jun 07; cited 2006 Jun 07]. Joining the WHO Programme for International Drug Monitoring; [about 4 screens]. Available from: http://www.who-umc.org/graphics/4805.pdf.
4. The Uppsala Monitoring Centre [homepage on the Internet]. Uppsala (Sweden): the Uppsala Monitoring Centre; c2006 [updated 2006 Feb 08; cited 2006 May 20]. Frequently asked questions about access to the WHO database; [about 2 screens]. Available from: http://www.who-umc.org/DynPage.aspx?id=30536.
5. The Uppsala Monitoring Centre [homepage on the Internet]. Uppsala (Sweden): the Uppsala Monitoring Centre; http://www.who-umc.org/DynPage.aspx?id=13140&mn=1514#6.
6. Olsson S. The role of the WHO programme on international drug monitoring in coordinating worldwide drug safety efforts. Drug Saf 19 (1998) 1-10
7. The importance of pharmacovigilance-safety monitoring of medicinal products. Geneva (Switzerland): World Health Organization; 2002, ISBN: 92-4-159015-7.
8. Bate A. Bayesian confidence propagation neural network. Drug Saf 30 (2007) 623-625
9. The Uppsala Monitoring Centre [homepage on the Internet]. Uppsala (Sweden): the Uppsala Monitoring Centre; c2006 [updated 2006 Feb 2; cited 2006 June 10]. Frequently asked questions about Vigimed; [about 2 screens]. Available from: http://www.who-umc.org/DynPage.aspx?id=30535.
10. Global Advisory Committee on Vaccine Safety, 9-10 June 2005. Wkly Epidemiol Rec 2005;80:242-7.
11. WHO consultation on global monitoring of adverse events following immunization, 9-10 January 2006. Wkly Epidemiol Rec 2006;81:261-5.
12. United Nations [homepage on the Internet]. United Nations; c2000-2006 [cited 2006 June 15]. World population prospects: the 2004 revision population database; [about 5 screens]. Available from: http://esa.un.org/unpp/.
13. World Health Organization [homepage on the Internet]. Geneva (Switzerland): World Health Organization; c2006 [cited 2006 July 11]. WHO/UNICEF joint reporting process; [about 4 screens]. Available from: http://www.who.int/immunization_monitoring/routine/joint_reporting/en/index.html.
14. The UMC Products & Services [homepage on the Internet]. Uppsala (Sweden): the Uppsala Monitoring Centre; c2006 [cited 2006 May 25]. WHO-ART-critical terms; [about 2 screens]. Available from: http://www.umc-products.com/DynPage.aspx?id=3421.
15. Edwards I.R., and Aronson J.K. Adverse drug reactions: definitions, diagnosis, and management. Lancet 356 (2000) 1255-1259
16. WHO Collaborating Centre for Drug Statistics Methodology [homepage on the Internet]. Oslo (Norway): WHO Collaborating Centre for Drug Statistics Methodology; c2006 [updated 2006 Jun 29; cited 2006 July 31]. Available from: http://www.whocc.no/atcddd/.
17. The Uppsala Monitoring Centre [homepage on the Internet]. Uppsala (Sweden): the Uppsala Monitoring Centre; c2006 [updated 2006 July 27; cited 2006 July 30]. The Anatomical Therapeutic Chemical (ATC) classification system; [about 2 screens]. Available from: http://www.who-umc.org/DynPage.aspx?id=30537.
18. United Nations [homepage on the Internet]. United Nations; c2000-2006 [updated 2006 July 3; cited 2006 July 11]. United Nations, Department of Economic and Social Affairs (DESA), Development Policy and Analysis Division (DPAD)-publications and reports by year; [about 5 screens]. Available from: http://www.un.org/esa/policy/publications/papers.htm.
19. Letourneau M, Wells G, Walop W, Duclos P. Improving global monitoring of vaccine safety: a survey of national centres participating in the WHO Programme for International Drug Monitoring Drug Safety, in press.